Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (411-420 of 495) with videos related to

Pageof 50
Sort By:
Oncology Letters|August 20, 2019
Expression of the immune checkpoint receptor TIGIT in seminomaAndrea Hinsch, Niclas C Blessin, Ronald Simon, et al.
Annals of Diagnostic Pathology|February 10, 2025
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypesPiero Caneve, Nina Schraps, Katharina Möller, et al.
EMBO Molecular Medicine|June 19, 2024
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanomaMark Sementsov, Leonie Ott, Julian Kött, et al.
Biomarker Research|June 6, 2021
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumorsEike Burandt, Felix Lübbersmeyer, Natalia Gorbokon, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumorsSimon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 TumorsAnne Menz, Nora Lony, Maximilian Lennartz, et al.
Disease Markers|February 9, 2019
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and CancerNiclas C Blessin, Ronald Simon, Martina Kluth, et al.
Neoplasia (New York, N.Y.)|August 23, 2017
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate CancerFrank Jacobsen, Juliane Kraft, Cornelia Schroeder, et al.
Analytical Cellular Pathology (Amsterdam)|August 22, 2022
Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 TumorsFlorian Viehweger, Lisa-Marie Tinger, David Dum, et al.
Frontiers in Oncology|May 20, 2026
Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumorsViktoria Chirico, Niklas Jahn, Seyma Büyücek, et al.
Pageof 50

Showing results (411-420 of 495) with videos related to

Sort By:
Pageof 50
Oncology Letters|August 20, 2019
Expression of the immune checkpoint receptor TIGIT in seminomaAndrea Hinsch, Niclas C Blessin, Ronald Simon, et al.
Annals of Diagnostic Pathology|February 10, 2025
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypesPiero Caneve, Nina Schraps, Katharina Möller, et al.
EMBO Molecular Medicine|June 19, 2024
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanomaMark Sementsov, Leonie Ott, Julian Kött, et al.
Biomarker Research|June 6, 2021
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumorsEike Burandt, Felix Lübbersmeyer, Natalia Gorbokon, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumorsSimon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 TumorsAnne Menz, Nora Lony, Maximilian Lennartz, et al.
Disease Markers|February 9, 2019
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and CancerNiclas C Blessin, Ronald Simon, Martina Kluth, et al.
Neoplasia (New York, N.Y.)|August 23, 2017
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate CancerFrank Jacobsen, Juliane Kraft, Cornelia Schroeder, et al.
Analytical Cellular Pathology (Amsterdam)|August 22, 2022
Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 TumorsFlorian Viehweger, Lisa-Marie Tinger, David Dum, et al.
Frontiers in Oncology|May 20, 2026
Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumorsViktoria Chirico, Niklas Jahn, Seyma Büyücek, et al.
Pageof 50